GE Healthcare dominates the CT market with new equipment sales, while sustaining an ascending market share trend. What's more, the breadth of the company’s portfolio ensures a steadily growing stream of revenues for its CT business unit.
Each year Frost & Sullivan presents this Award to a company that has demonstrated market share leadership through the implementation of market strategy. GE Healthcare has displayed excellence in all areas of the market leadership process, including the identification of market challenges, drivers and restraints, as well as strategy development and methods of addressing these market dynamics.
“GE Healthcare has set the pace in CT technology with a performance unmatched by its competitors,” said Frost & Sullivan research analyst Nadim Daher. “Launched in 2004, GE's LightSpeed VCT helped inaugurate a new generation of CT capabilities such as scanning the heart in as little as 5 seconds, rather than just focusing on the number of slices.”
As the market praised the phenomenal capabilities of GE’s LightSpeed VCT, notably, its image quality, reliability and its angiography and cardiac imaging capabilities, the premium system continues to be an overwhelming commercial success. Touting the highest market adoption rate in the industry with a global installed base of over 1500systems, the technology crosses all segments of the healthcare provider spectrum.
GE demonstrates that a strong sense of vendor responsibility and consideration of the customers' needs, concerns and aspirations are the keys to further innovation. Clinical relevance is the cornerstone of GE’s approach of advancing technology with a focus on clinical applications, workflow and dose efficiency.
“GE has also proven to be highly attentive to the rise of dose-consciousness among U.S. radiologists,” noted Daher. “Understanding that coronary CTA, an extremely important new CT application, also happened to be one of the CT examinations with the highest-relative dose, GE released the new LightSpeed VCT XT version that offers as much as a seventy percent dose reduction with uncompromised image quality.”
GE works with leading academic sites to continually develop breakthrough applications for CT. Realizing that current CT technology is not utilized to its full potential, GE has invigorated its sponsorship and participation in large, highly promising clinical trials.
GE is investigating interesting developments on Volume Dual Energy acquisitions performed on a single-source scanner with a wide field of view, as well as a Helical Shuttle mode investigation.
GE Healthcare recognizes it is essential to streamline the workflow and improve the productivity of technologists, nurses, radiologists, and referring physicians. GE's latest innovations provide users with software that is more efficient for a more practical workflow and more powerful for a more robust application-specific workflow.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit or .